TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms

por Rauert, H, Stühmer, T, Bargou, R, Wajant, H, Siegmund, D
Publicado 2011

Sunitinib in metastatic thymic carcinomas: Laboratory findings and initial clinical experience

por Ströbel, P, Bargou, R, Wolff, A, Spitzer, D, Manegold, C, Dimitrakopoulou-Strauss, A, Strauss, L, Sauer, C, Mayer, F, Hohenberger, P, Marx, A
Publicado 2010

Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules

por Leich, E, Weißbach, S, Klein, H-U, Grieb, T, Pischimarov, J, Stühmer, T, Chatterjee, M, Steinbrunn, T, Langer, C, Eilers, M, Knop, S, Einsele, H, Bargou, R, Rosenwald, A
Publicado 2013

Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia

por Zugmaier, G, Topp, M S, Alekar, S, Viardot, A, Horst, H-A, Neumann, S, Stelljes, M, Bargou, R C, Goebeler, M, Wessiepe, D, Degenhard, E, Gökbuget, N, Klinger, M
Publicado 2014

Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia

por Topp, M S, Stelljes, M, Zugmaier, G, Barnette, P, Heffner, L T, Trippett, T, Duell, J, Bargou, R C, Holland, C, Benjamin, J E, Klinger, M, Litzow, M R
Publicado 2018

Early clinical trial unit tumor board: a real-world experience in a national cancer network

por Weiss, L., Dorman, K., Boukovala, M., Schwinghammer, F., Jordan, P., Fey, T., Hasselmann, K., Subklewe, M., Bücklein, V., Bargou, R., Goebeler, M., Sayehli, C., Spoerl, S., Lüke, F., Heudobler, D., Claus, R., von Luettichau, I., Lorenzen, S., Lange, S., Westphalen, C. B., von Bergwelt-Baildon, M., Heinemann, V., Gießen-Jung, C.
Publicado 2023